Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Lowes | LOW | Sep 19, 2024 | 261.00 | +1.70 |
LPL Financial | LPLA | Sep 19, 2024 | 220.83 | +4.12 |
LQR House | LQR | Sep 19, 2024 | 0.63 | +2.89 |
LSB Industries | LXU | Sep 19, 2024 | 8.01 | +5.67 |
LSI Industries | LYTS | Sep 19, 2024 | 16.01 | +2.10 |
Ltc Properties | LTC | Sep 19, 2024 | 36.50 | -2.17 |
Lucas GC | LGCL | Sep 19, 2024 | 1.20 | 0.00 |
Lucid Diagnostics | LUCD | Sep 19, 2024 | 0.82 | -1.59 |
Lucid Group | LCID | Sep 19, 2024 | 3.61 | -0.82 |
Lufax ADR | LU | Sep 19, 2024 | 2.29 | +3.62 |
Lululemon Athletica | LULU | Sep 19, 2024 | 270.76 | +0.21 |
Lulus Fashion Lounge | LVLU | Sep 19, 2024 | 1.45 | +5.07 |
Lumen Technologies | LUMN | Sep 19, 2024 | 6.70 | +5.02 |
Lument Finance Trust | LFT | Sep 19, 2024 | 2.59 | +1.57 |
Lument Finance Trust A Pref | LFT-A | Sep 19, 2024 | 22.00 | +1.29 |
Lumentum | LITE | Sep 19, 2024 | 61.14 | +4.91 |
Luminar Technologies A | LAZR | Sep 19, 2024 | 0.79 | -0.03 |
Lumos Pharma | LUMO | Sep 19, 2024 | 3.92 | +5.95 |
Luna Innovations | LUNA | Sep 19, 2024 | 2.27 | +3.42 |
Luokung Technology | LKCO | Sep 19, 2024 | 2.77 | +5.32 |
Luxfer | LXFR | Sep 19, 2024 | 12.73 | +2.41 |
LuxUrban Hotels | LUXH | Sep 19, 2024 | 0.07 | +1.70 |
Luxurban Hotels Pref | LUXHP | Sep 19, 2024 | 16.25 | 0.00 |
Lxp Industrial Trust | LXP | Sep 19, 2024 | 10.30 | +1.48 |
LXP Industrial Trust C Pref | LXP-C | Sep 19, 2024 | 52.89 | +0.36 |
Lyell Immunopharma | LYEL | Sep 19, 2024 | 1.56 | +15.56 |
Lyft A | LYFT | Sep 19, 2024 | 12.53 | +2.96 |
LyondellBasell Industries Nv A | LYB | Sep 19, 2024 | 96.09 | +2.29 |
Lyra Therapeutics | LYRA | Sep 19, 2024 | 0.28 | +2.67 |
Lytus Technologies | LYT | Sep 19, 2024 | 1.92 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.